DE602004016385D1 - Zusammensetzungen mit pantothensäure oder derivaten davon und ihre verwendung zur stimulierung des appetits - Google Patents
Zusammensetzungen mit pantothensäure oder derivaten davon und ihre verwendung zur stimulierung des appetitsInfo
- Publication number
- DE602004016385D1 DE602004016385D1 DE602004016385T DE602004016385T DE602004016385D1 DE 602004016385 D1 DE602004016385 D1 DE 602004016385D1 DE 602004016385 T DE602004016385 T DE 602004016385T DE 602004016385 T DE602004016385 T DE 602004016385T DE 602004016385 D1 DE602004016385 D1 DE 602004016385D1
- Authority
- DE
- Germany
- Prior art keywords
- compositions
- pantothenic acid
- derivatives
- stimulate appetite
- appetite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 title abstract 2
- 230000036528 appetite Effects 0.000 title abstract 2
- 235000019789 appetite Nutrition 0.000 title abstract 2
- 229940055726 pantothenic acid Drugs 0.000 title abstract 2
- 235000019161 pantothenic acid Nutrition 0.000 title abstract 2
- 239000011713 pantothenic acid Substances 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Inorganic Chemistry (AREA)
- Pediatric Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03079190 | 2003-12-24 | ||
PCT/NL2004/000910 WO2005060952A1 (en) | 2003-12-24 | 2004-12-24 | Compositions comprising pantothenic acid or derivatives thereof and their use for stimulating appetite |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004016385D1 true DE602004016385D1 (de) | 2008-10-16 |
Family
ID=34707256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004016385T Active DE602004016385D1 (de) | 2003-12-24 | 2004-12-24 | Zusammensetzungen mit pantothensäure oder derivaten davon und ihre verwendung zur stimulierung des appetits |
Country Status (8)
Country | Link |
---|---|
US (1) | US8388949B2 (de) |
EP (3) | EP2002830A1 (de) |
JP (1) | JP2007517026A (de) |
CN (1) | CN1921842A (de) |
AT (1) | ATE406884T1 (de) |
DE (1) | DE602004016385D1 (de) |
ES (1) | ES2314485T3 (de) |
WO (1) | WO2005060952A1 (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8252309B2 (en) * | 2000-04-04 | 2012-08-28 | Sigma-Tau Industrie Farmaceutiche Riunite Spa | Dietary supplement energy-providing to skeletal muscles |
US20050215640A1 (en) | 2004-03-26 | 2005-09-29 | Baxter Jeffrey H | HMB compositions and uses thereof |
DK2275140T3 (en) * | 2004-07-19 | 2018-02-05 | Bergen Teknologioverforing As | Composition, comprising plant and / or fish oils and non-oxidizable fatty acid units |
RU2469719C2 (ru) | 2005-12-19 | 2012-12-20 | Абботт Лаборэтриз | СПОСОБ ЛЕЧЕНИЯ АЛЛЕРГИИ, СПОСОБ ЛЕЧЕНИЯ АСТМЫ, СПОСОБ СНИЖЕНИЯ РИСКА РАЗВИТИЯ ИНФЕКЦИИ И СПОСОБ ЛЕЧЕНИЯ СОСТОЯНИЯ, ХАРАКТЕРИЗУЮЩЕГОСЯ ДИСБАЛАНСОМ СОДЕРЖАНИЯ ЦИТОКИНОВ ТИПОВ 1 И 2, ПОСРЕДСТВОМ β-ГИДРОКСИ-β-МЕТИЛБУТИРАТА |
EP1911457A1 (de) * | 2006-10-12 | 2008-04-16 | N.V. Nutricia | Zusammensetzung zur Behandlung oder Vorbeugung von Magen-Darm-Infektionen |
US20080146579A1 (en) * | 2006-12-15 | 2008-06-19 | N.V. Nutricia | Treatment of patients with chronic pulmonary diseases and nutritional compositions therefore |
ITMI20081405A1 (it) * | 2008-07-29 | 2010-01-30 | Velleja Res Srl | Formulazioni orali istantanee, gelificanti a temperatura ambiente, utili per contrastare il deperimento organico e la sindrome depressiva connessi a cachessia, anoressia, malattia metabolica, malattia endocrina e disfagia |
WO2010126353A1 (en) | 2009-04-27 | 2010-11-04 | N.V. Nutricia | Pea-based protein mixture and use thereof in a liquid nutritional composition suitable for enteral feeding |
CA3031481C (en) | 2009-07-10 | 2021-03-16 | Linzy O. Scott, Iii | Methods and compositions for treating thyroid-related medical conditions with reduced folates |
EP2528459B1 (de) | 2010-01-29 | 2014-06-11 | Abbott Laboratories | Nährstoffemulsionen mit calcium-hmb |
CA2785523A1 (en) | 2010-01-29 | 2011-08-04 | Abbott Laboratories | Aseptically packaged nutritional liquids comprising hmb |
US9693577B2 (en) | 2010-01-29 | 2017-07-04 | Abbott Laboratories | Method of preparing a nutritional powder comprising spray dried HMB |
TWI526161B (zh) | 2010-06-10 | 2016-03-21 | 亞培公司 | 包含鈣hmb及可溶性蛋白質之實質上透明營養液 |
CN103153095B (zh) * | 2010-08-24 | 2015-07-22 | 雅培制药有限公司 | 具有改良感官特性的营养产品 |
WO2012091542A1 (en) | 2010-12-28 | 2012-07-05 | N.V. Nutricia | Combination of components for the prevention and treatment of frailty |
BR112014001404A2 (pt) | 2011-07-22 | 2017-03-01 | Fresenius Kabi Deutschland Gmbh | produto para a nutrição parenteral de pacientes de tratamento intensivo obesos |
US9198454B2 (en) * | 2012-03-08 | 2015-12-01 | Nusirt Sciences, Inc. | Compositions, methods, and kits for regulating energy metabolism |
WO2014007606A1 (en) * | 2012-07-05 | 2014-01-09 | N.V. Nutricia | Product for use in the prophylactic or therapeutic treatment of a negative emotion or introvert behaviour |
WO2016029074A1 (en) * | 2014-08-22 | 2016-02-25 | Abbott Laboratories | Nutritional beverage containing rice protein |
US11197917B2 (en) | 2017-12-01 | 2021-12-14 | ByHeart, Inc. | Formulations for nutritional support in subjects in need thereof |
JP2019140952A (ja) * | 2018-02-19 | 2019-08-29 | 株式会社コンプ | 経口摂取用栄養調整食品 |
CN111920793A (zh) * | 2019-04-25 | 2020-11-13 | 瑞微(深圳)生物科技有限公司 | 泛酸在制备用于治疗和/或预防肿瘤的组合物中的应用 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4497800A (en) * | 1982-07-06 | 1985-02-05 | Mead Johnson & Company | Stable liquid diet composition |
IT1169460B (it) | 1982-09-13 | 1987-05-27 | Sigma Tau Ind Farmaceuti | Metodo e composizione per il trattamento di tumori |
IT1157238B (it) * | 1982-10-29 | 1987-02-11 | Sigma Tau Ind Farmaceuti | Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile |
GB8922701D0 (en) | 1989-10-09 | 1989-11-22 | Leung Lit Hung | Compositions and methods for weight reduction |
JPH05294833A (ja) * | 1991-04-15 | 1993-11-09 | Takeda Chem Ind Ltd | ビタミン含有保健剤 |
DE4304394A1 (en) * | 1993-02-13 | 1993-09-02 | Fresenius Ag | Prepn. for nourishment of oncological patients - comprises fats formulation contg. oleic acid, alpha-linolenic acid, etc., and opt. carbohydrate and proteins |
CN1097563A (zh) * | 1993-07-23 | 1995-01-25 | 陈远星 | 采用兰类植物的饮料及其制造方法 |
JPH07233070A (ja) * | 1994-02-23 | 1995-09-05 | Taisho Pharmaceut Co Ltd | 疲労改善剤 |
CA2173780A1 (en) * | 1995-06-01 | 1996-12-02 | Randy Grote | Method for providing nutrition in a variety of compositional forms |
US5958464A (en) * | 1996-02-08 | 1999-09-28 | Register; Jack W. | Veterinary pharmaceutical composition |
US6077828A (en) | 1996-04-25 | 2000-06-20 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
US5922766A (en) * | 1997-07-02 | 1999-07-13 | Acosta; Phyllis J. B. | Palatable elemental medical food |
EP0920813A1 (de) * | 1997-12-08 | 1999-06-09 | Societe Des Produits Nestle S.A. | Beschleunigung der Verdauung einer Protein |
ID24710A (id) * | 1998-05-12 | 2000-08-03 | Nutricia Nv | Komposisi nutrisi untuk perawatan luka karena tekanan |
JP2001008637A (ja) * | 1999-06-25 | 2001-01-16 | Shinkyo Sangyo Kk | 家畜用飼料 |
DE29916231U1 (de) | 1999-09-15 | 2000-02-17 | Renner Jobst | Multivitamin- und -mineralpräparat |
US6399114B2 (en) * | 2000-05-26 | 2002-06-04 | C & D Foreman, Inc. | Nutritional system for nervous system disorders |
NZ507335A (en) * | 2000-10-05 | 2004-10-29 | New Zealand Dairy Board | Bone health compositions derived from milk comprising an acidic protein fraction but that does not contain CGMP |
WO2003004673A1 (en) | 2001-07-03 | 2003-01-16 | Degussa Ag | Process for the fermentative preparation of d-pantothenic acid and/or salts thereof |
US6495149B1 (en) | 2001-08-10 | 2002-12-17 | The Procter & Gamble Company | Topical leave-on compositions containing selected pantothenic acid derivatives |
DE10147960A1 (de) | 2001-09-28 | 2003-04-10 | Degussa | Verfahren zur fermentativen Herstellung von D-Panthothensäure und/oder deren Salzen |
-
2004
- 2004-12-24 JP JP2006546872A patent/JP2007517026A/ja active Pending
- 2004-12-24 WO PCT/NL2004/000910 patent/WO2005060952A1/en active Application Filing
- 2004-12-24 CN CNA200480042052XA patent/CN1921842A/zh active Pending
- 2004-12-24 EP EP08163489A patent/EP2002830A1/de not_active Withdrawn
- 2004-12-24 EP EP04808826A patent/EP1699447B1/de not_active Not-in-force
- 2004-12-24 US US10/584,510 patent/US8388949B2/en not_active Expired - Fee Related
- 2004-12-24 ES ES04808826T patent/ES2314485T3/es active Active
- 2004-12-24 AT AT04808826T patent/ATE406884T1/de not_active IP Right Cessation
- 2004-12-24 EP EP10186192A patent/EP2311448A1/de not_active Withdrawn
- 2004-12-24 DE DE602004016385T patent/DE602004016385D1/de active Active
Also Published As
Publication number | Publication date |
---|---|
US8388949B2 (en) | 2013-03-05 |
EP1699447B1 (de) | 2008-09-03 |
EP2002830A1 (de) | 2008-12-17 |
JP2007517026A (ja) | 2007-06-28 |
EP2311448A1 (de) | 2011-04-20 |
CN1921842A (zh) | 2007-02-28 |
EP1699447A1 (de) | 2006-09-13 |
WO2005060952A1 (en) | 2005-07-07 |
ES2314485T3 (es) | 2009-03-16 |
ATE406884T1 (de) | 2008-09-15 |
US20080031860A1 (en) | 2008-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602004016385D1 (de) | Zusammensetzungen mit pantothensäure oder derivaten davon und ihre verwendung zur stimulierung des appetits | |
ATE432072T1 (de) | Verwendung von adapalen zur behandlung dermatologischer erkrankungen | |
DE60319865D1 (de) | Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen | |
ATE281085T1 (de) | Nahrungsergänzung zur behandlung von makula degeneration | |
HRP20110566T8 (en) | Azaindoles useful as inhibitors of jak and other protein kinases | |
ATE448206T1 (de) | Benzochinazolinderivate und ihre verwendung bei der behandlung von knochenerkrankungen | |
DE60303238D1 (de) | Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten | |
DE602004014117D1 (de) | Thiazole zur verwendung als inhibitoren von protein-kinasen | |
DE602004031134D1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
DK1455603T3 (da) | Stimulering af in vivo produktion af proteiner med en formulering, der omfatter leucin | |
BR0315689A (pt) | Alvo para terapia de dano cognitivo | |
EP1614675A3 (de) | Aminosäuren mit affinität zu alpha2-delta-protein | |
DE60318839D1 (de) | 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten | |
ATE336996T1 (de) | Verwendung von flavonoid-derivaten zur behandlung von atopischem ekzem | |
WO2005020928A3 (en) | Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins | |
ATE516040T1 (de) | Zusammensetzung und verwendung zur vorbeugung oder behandlung von stomatitis | |
DE50305507D1 (de) | Zusammensetzungen zur herstellung von aminoplasterzeugnissen | |
DE60206289D1 (de) | Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne | |
ATE267816T1 (de) | Tan-1057 derivate | |
DE60313803D1 (de) | Cathepsincysteinproteaseinhibitoren und deren verwendung zur behandlung von entzündungen und immunerkrankungen | |
DE602004001509D1 (de) | Verwendung von hsp20 zur förderung der wundheilung und / oder zur reduzierung von narbenbildung | |
EA200600777A1 (ru) | N-замещённые пиразолилкарбоксанилиды | |
AU2003245989A8 (en) | Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases | |
DE60322983D1 (de) | Pflanzliche zusammensetzung zur behandlung von gastrointestinalen erkrankungen | |
ATE420074T1 (de) | Bengamide-derivate und deren verwendung zur behandlung von krebserkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |